A new drug that may stop a gene associated with obesity from triggering breast and lung cancer, as well as prevent these cancers from growing, is in testing stages, scientists say.

The drug, I-BET-762, was found showing signs of significantly delaying the development of existing breast and lung cancers by zeroing in on how a cancerous gene, called c-Myc, acts.